Multiple myeloma (MM), characterized by cancerous proliferation of plasmablasts (PB) and plasma cells (PC), remains incurable in many patients. Differentially expressed molecules between MM PCs and healthy PCs have been explored in order to identify novel targets for treating MM. | Gm40600 suppressed SP 2 0 isograft tumor by reducing Blimp1 and Xbp1 proteins